Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules

In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that re...

Full description

Saved in:
Bibliographic Details
Published inPhilosophical transactions of the Royal Society of London. Series B. Biological sciences Vol. 367; no. 1590; pp. 800 - 811
Main Authors Parham, Peter, Norman, Paul J., Abi-Rached, Laurent, Guethlein, Lisbeth A.
Format Journal Article
LanguageEnglish
Published England The Royal Society 19.03.2012
Subjects
Online AccessGet full text
ISSN0962-8436
1471-2970
1471-2970
DOI10.1098/rstb.2011.0266

Cover

Abstract In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.
AbstractList In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.
In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.
In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity-combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands-drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity-combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands-drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.
Author Abi-Rached, Laurent
Parham, Peter
Norman, Paul J.
Guethlein, Lisbeth A.
AuthorAffiliation 2 Department of Microbiology and Immunology , Stanford University , Stanford, CA 94305 , USA
1 Department of Structural Biology , Stanford University , Stanford, CA 94305 , USA
AuthorAffiliation_xml – name: 1 Department of Structural Biology , Stanford University , Stanford, CA 94305 , USA
– name: 2 Department of Microbiology and Immunology , Stanford University , Stanford, CA 94305 , USA
Author_xml – sequence: 1
  givenname: Peter
  surname: Parham
  fullname: Parham, Peter
  email: peropa@stanford.edu
  organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA
– sequence: 2
  givenname: Paul J.
  surname: Norman
  fullname: Norman, Paul J.
  organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA
– sequence: 3
  givenname: Laurent
  surname: Abi-Rached
  fullname: Abi-Rached, Laurent
  organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA
– sequence: 4
  givenname: Lisbeth A.
  surname: Guethlein
  fullname: Guethlein, Lisbeth A.
  organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22312047$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQjVAR_YArN1BucMnWX7GTCxKsKK1UgdQWerQcx9l617GDnSxdfgC_G4e0CwW1nPwx772ZeTP7yY51ViXJcwhmEJTFoQ99NUMAwhlAlD5K9iBhMEMlAzvJHigpygqC6W6yH8ISAFDmjDxJdhHCEAHC9pIfx0MrbBY6JXWjZarWzgy9djZ1TbrSxiifSmVMqtt2sG5hXDUYbTOjVyr1Sqqud368uIXVt7xWLOPnlQ69k67tRK8rbXS_SceXUdepNCKE9CRtnVFyMCo8TR43wgT17OY8SD4fvb-YH2ennz6czN-eZpIi2me1ErG9EmMoBEGQVYBBUsAGV0A1KM_rukaIoJpUNKcVzgEpaqRQqUglGwAJPkgOJ93BdmLzTRjDO69b4TccAj46ykdH-egoHx2NjDcToxuqVtVS2d6L3ywnNL8bsfqKL9yaY0QZhDgKvLoR8O7roELPWx1GS4VVbgi8RADTklEQka8fREIAigJFA1CEvvyzqm05t4ONgNkEkN6F4FXz_z7JXwSpezFONHalzf201UTzbhMH56RW_YYv3eBtfPKz84t3a0yZhnkJOCgwBBQDkvPvupukYpDrEAbFf0Huyv-bDT-U7d4aX0ysZVxIvzWCQEIgw-OEsikeF1Zdb-PCrzhlmOX8S0H4x6Ozy_n5HPBL_BNoixf1
CitedBy_id crossref_primary_10_1007_s00251_015_0828_3
crossref_primary_10_3390_cancers11070996
crossref_primary_10_4049_jimmunol_1900423
crossref_primary_10_1111_iji_12515
crossref_primary_10_1093_toxsci_kfz098
crossref_primary_10_3389_fimmu_2015_00268
crossref_primary_10_1016_j_humgen_2022_201086
crossref_primary_10_1084_jem_20152023
crossref_primary_10_3389_fimmu_2015_00540
crossref_primary_10_1007_s00005_015_0350_1
crossref_primary_10_3892_mco_2016_1106
crossref_primary_10_1002_mco2_626
crossref_primary_10_3389_fimmu_2021_640334
crossref_primary_10_4049_jimmunol_1401689
crossref_primary_10_3389_fimmu_2018_01345
crossref_primary_10_1016_j_bbmt_2019_10_032
crossref_primary_10_1371_journal_ppat_1010612
crossref_primary_10_3390_biom13050748
crossref_primary_10_1007_s00251_017_1038_y
crossref_primary_10_1007_s00251_022_01259_4
crossref_primary_10_1146_annurev_animal_022513_114234
crossref_primary_10_4049_jimmunol_1500227
crossref_primary_10_3389_fimmu_2016_00060
crossref_primary_10_1111_tan_15177
crossref_primary_10_1007_s11427_018_9458_0
crossref_primary_10_1093_ilar_ilt043
crossref_primary_10_5500_wjt_v6_i3_532
crossref_primary_10_3389_fimmu_2023_1135148
crossref_primary_10_1007_s00262_015_1750_0
crossref_primary_10_1186_s40246_022_00429_5
crossref_primary_10_3389_fimmu_2017_00212
crossref_primary_10_1002_ajhb_23545
crossref_primary_10_4049_jimmunol_1300111
crossref_primary_10_1016_j_humimm_2018_10_003
crossref_primary_10_1016_j_critrevonc_2020_103206
crossref_primary_10_1111_jcpe_12212
crossref_primary_10_1016_j_jim_2015_07_008
crossref_primary_10_1002_rmb2_12610
crossref_primary_10_1016_j_gde_2014_08_001
crossref_primary_10_1111_imr_12325
crossref_primary_10_1182_bloodadvances_2023009827
crossref_primary_10_1016_j_humimm_2015_10_019
crossref_primary_10_4049_jimmunol_1602163
crossref_primary_10_1007_s00251_020_01161_x
crossref_primary_10_3389_fgene_2021_774916
crossref_primary_10_4049_jimmunol_1300081
crossref_primary_10_1111_imr_12323
crossref_primary_10_1007_s00251_013_0752_3
crossref_primary_10_1038_srep42470
crossref_primary_10_1111_iji_12490
crossref_primary_10_4049_jimmunol_1801363
crossref_primary_10_1146_annurev_biochem_011520_102754
crossref_primary_10_7554_eLife_75670
crossref_primary_10_3389_fimmu_2017_00832
crossref_primary_10_1007_s00251_014_0778_1
crossref_primary_10_1186_s40364_024_00610_z
crossref_primary_10_1038_s41571_020_0426_7
crossref_primary_10_1086_706768
crossref_primary_10_3389_fimmu_2014_00105
crossref_primary_10_1016_j_jaip_2022_04_036
crossref_primary_10_1111_imr_12316
crossref_primary_10_1016_j_humimm_2017_05_002
crossref_primary_10_3389_fimmu_2023_1308316
crossref_primary_10_1016_j_jri_2021_103425
crossref_primary_10_1371_journal_pone_0163297
crossref_primary_10_1111_tan_12523
crossref_primary_10_1111_imm_12137
crossref_primary_10_1371_journal_pbio_1002144
crossref_primary_10_1016_j_repbio_2015_08_001
crossref_primary_10_1111_tan_13971
crossref_primary_10_3389_fimmu_2022_992723
crossref_primary_10_1098_rstb_2011_0318
crossref_primary_10_3389_fmed_2023_1148748
crossref_primary_10_3390_vaccines8040677
crossref_primary_10_1111_iji_12433
crossref_primary_10_1016_j_eimc_2013_10_007
crossref_primary_10_3390_ijms23137030
crossref_primary_10_1016_j_humimm_2017_07_010
crossref_primary_10_1002_ajhb_22391
crossref_primary_10_1093_molbev_msz249
crossref_primary_10_1016_j_trim_2017_10_002
crossref_primary_10_3389_fimmu_2018_02991
crossref_primary_10_1177_0961203316638931
crossref_primary_10_1146_annurev_med_052511_135400
crossref_primary_10_1002_eji_201545757
crossref_primary_10_1111_cei_12582
crossref_primary_10_1158_0008_5472_CAN_12_3322
crossref_primary_10_1186_s12967_022_03437_0
crossref_primary_10_3389_fimmu_2024_1423149
crossref_primary_10_1101_gr_137976_112
crossref_primary_10_1371_journal_pone_0141536
crossref_primary_10_1016_j_jri_2012_10_009
crossref_primary_10_3389_fimmu_2021_755624
crossref_primary_10_1186_s12865_024_00631_1
crossref_primary_10_3390_cancers13071536
crossref_primary_10_1146_annurev_immunol_042617_053149
crossref_primary_10_1098_rstb_2014_0070
crossref_primary_10_1016_j_humimm_2018_03_010
crossref_primary_10_1016_j_placenta_2011_11_020
crossref_primary_10_1016_j_coi_2017_11_003
crossref_primary_10_1371_journal_pone_0180831
crossref_primary_10_1007_s11033_019_04900_w
crossref_primary_10_1038_s41467_021_22359_x
crossref_primary_10_1111_tan_12423
crossref_primary_10_1111_tan_13754
crossref_primary_10_1111_tan_13996
crossref_primary_10_1111_imm_13289
crossref_primary_10_1089_scd_2012_0402
crossref_primary_10_1002_JLB_6RI0917_390R
crossref_primary_10_1016_j_xagr_2024_100321
crossref_primary_10_1073_pnas_1322052111
crossref_primary_10_1093_infdis_jiy492
crossref_primary_10_1111_ajt_12134
crossref_primary_10_4049_jimmunol_1701480
crossref_primary_10_4049_jimmunol_1100431
crossref_primary_10_1007_s00005_017_0474_6
crossref_primary_10_1155_2015_427217
crossref_primary_10_3389_fimmu_2019_00177
crossref_primary_10_4049_jimmunol_1401980
crossref_primary_10_1007_s00251_017_1017_3
crossref_primary_10_1016_j_humimm_2013_04_028
crossref_primary_10_1371_journal_pntd_0002744
crossref_primary_10_1016_j_humimm_2015_03_022
crossref_primary_10_3389_fimmu_2021_716289
crossref_primary_10_1126_sciimmunol_aag1672
crossref_primary_10_1371_journal_pone_0064936
crossref_primary_10_1007_s00251_015_0888_4
crossref_primary_10_1371_journal_pgen_1005439
crossref_primary_10_1111_tan_12299
crossref_primary_10_3389_fimmu_2023_1269614
crossref_primary_10_1111_tan_13817
crossref_primary_10_1111_tan_13939
crossref_primary_10_3389_fgene_2022_829891
crossref_primary_10_3389_fmicb_2015_01061
crossref_primary_10_1111_aji_12453
crossref_primary_10_1007_s00251_016_0918_x
crossref_primary_10_1016_j_jconrel_2023_08_014
crossref_primary_10_4049_jimmunol_1901140
crossref_primary_10_1111_mec_13468
crossref_primary_10_1007_s00005_013_0225_2
crossref_primary_10_1200_JCO_2012_47_4007
crossref_primary_10_1016_j_humimm_2015_01_020
crossref_primary_10_1073_pnas_1903781116
crossref_primary_10_1155_2016_2079704
crossref_primary_10_1111_sji_12348
Cites_doi 10.4049/jimmunol.0901734
10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E
10.4049/jimmunol.1000078
10.4049/jimmunol.156.9.3098
10.1093/nar/gkq1128
10.1016/j.it.2010.05.007
10.4049/jimmunol.178.1.33
10.4049/jimmunol.178.2.647
10.1146/annurev.iy.11.040193.003145
10.4049/jimmunol.0803401
10.4049/jimmunol.0803026
10.1016/j.smim.2008.06.003
10.1016/0167-5699(90)90097-S
10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P
10.1073/pnas.95.24.14326
10.1016/j.humimm.2005.11.007
10.1182/blood-2009-12-256586
10.1084/jem.20051884
10.1007/s00251-007-0214-x
10.1111/j.1365-2567.2010.03398.x
10.1073/pnas.94.12.6313
10.1126/science.1097670
10.4049/jimmunol.0903016
10.1016/j.gene.2004.03.018
10.1371/journal.pone.0015115
10.1007/s00251-006-0108-3
10.1016/j.smim.2008.09.007
10.4049/jimmunol.169.1.220
10.1182/blood-2009-07-231977
10.1016/j.placenta.2009.12.022
10.1016/S1074-7613(00)80219-8
10.4049/jimmunol.172.1.356
10.1084/jem.185.8.1523
10.1016/j.immuni.2006.06.013
10.4049/jimmunol.0902332
10.1126/science.1198687
10.1371/journal.pgen.1001249
10.1016/j.it.2011.02.003
10.4049/jimmunol.181.9.6293
10.1038/gene.2008.91
10.1007/s00251-002-0529-6
10.1186/1471-2164-7-209
10.1016/j.smim.2008.05.004
10.1172/JCI43998
10.1182/blood-2008-03-143727
10.1038/nri1570
10.1002/eji.1830270517
10.1182/blood-2008-07-171926
10.1007/s00251-008-0342-y
10.1084/jem.189.7.1093
10.1101/gr.2381205
10.3324/haematol.2009.021121
10.4049/jimmunol.161.2.571
10.1016/S0161-5890(02)00030-5
10.1007/978-3-642-48287-8
10.1002/eji.1830271203
10.1073/pnas.0906051106
10.1038/ng2035
10.1182/blood-2008-10-184549
10.1016/j.immuni.2006.03.006
10.1073/pnas.0913745107
10.1073/pnas.1003865108
10.1016/j.molimm.2010.10.014
10.4049/jimmunol.158.9.4026
10.1371/journal.pgen.1001192
10.1371/journal.pgen.1000688
10.1002/eji.200425089
10.1007/s00251-011-0535-7
10.1084/jem.180.4.1235
10.4049/jimmunol.166.7.4380
10.4049/jimmunol.169.9.5118
10.1084/jem.20041214
10.1182/blood-2004-12-4825
10.4049/jimmunol.179.1.491
10.1016/j.ygeno.2004.01.010
10.4049/jimmunol.1001494
10.1038/nature09534
10.4049/jimmunol.168.1.240
10.1084/jem.20091010
10.1093/humrep/den011
10.1084/jem.20020304
10.1056/NEJM198906293202605
10.1038/nri1897
10.1038/35869
10.1073/pnas.080588597
10.1073/pnas.94.9.4604
10.1371/journal.pgen.0010027
10.1126/science.1068440
10.1016/S1074-7613(00)80394-5
10.4049/jimmunol.1001951
ContentType Journal Article
Copyright Copyright © 2012 The Royal Society
This journal is © 2012 The Royal Society
This journal is © 2012 The Royal Society 2012
Copyright_xml – notice: Copyright © 2012 The Royal Society
– notice: This journal is © 2012 The Royal Society
– notice: This journal is © 2012 The Royal Society 2012
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
5PM
ADTOC
UNPAY
DOI 10.1098/rstb.2011.0266
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Sciences (General)
Biology
DocumentTitleAlternate Review. Coevolution of KIR and HLA class I
EISSN 1471-2970
EndPage 811
ExternalDocumentID 10.1098/rstb.2011.0266
PMC3267113
22312047
10_1098_rstb_2011_0266
41441733
ark_67375_V84_NFRWCSC0_W
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI17892
– fundername: NIAID NIH HHS
  grantid: R01 AI017892
– fundername: NIAID NIH HHS
  grantid: AI22039
– fundername: NIAID NIH HHS
  grantid: R01 AI022039
GroupedDBID ---
-~X
0R~
29O
2WC
4.4
53G
AACGO
AANCE
ABBHK
ABPLY
ABTLG
ABXSQ
ACPRK
ACQIA
ACSFO
ADACV
ADBBV
ADULT
AEUPB
AEXZC
AFRAH
AJZGM
ALMA_UNASSIGNED_HOLDINGS
ALMYZ
AOIJS
AQVQM
BAWUL
BGBPD
BSCLL
BTFSW
DCCCD
DIK
DOOOF
E3Z
EBS
EJD
F5P
GX1
H13
HYE
HZ~
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
K-O
KQ8
MRS
MV1
NSAHA
O9-
OK1
OP1
RPM
RRY
SA0
TN5
V1E
W8F
YNT
~02
ACHIC
ACRPL
ADNMO
ADQXQ
AGPVY
AGQPQ
ABPTK
ABXXB
ADZLD
DNJUQ
DWIUU
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
5PM
AANZV
ABIEJ
ACMKX
ADTOC
AS~
CAG
COF
HGD
HQ3
HTVGU
MVM
ROL
UNPAY
WHG
WOQ
ID FETCH-LOGICAL-c626t-dea4719331aa4217b071481f3b0ef255ddd2242d4b656b35048d2e29e4bcf0143
IEDL.DBID UNPAY
ISSN 0962-8436
1471-2970
IngestDate Sun Oct 26 04:09:48 EDT 2025
Tue Sep 30 15:40:25 EDT 2025
Fri Jul 11 09:43:52 EDT 2025
Thu Oct 02 06:02:44 EDT 2025
Thu Apr 03 07:01:06 EDT 2025
Tue Jul 01 03:25:14 EDT 2025
Thu Apr 24 23:05:28 EDT 2025
Wed Jan 17 02:37:36 EST 2024
Tue May 24 16:17:26 EDT 2022
Thu Jul 03 21:17:23 EDT 2025
Tue Sep 24 00:40:25 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1590
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c626t-dea4719331aa4217b071481f3b0ef255ddd2242d4b656b35048d2e29e4bcf0143
Notes One contribution of 14 to a Discussion Meeting Issue ‘Immunity, infection, migration and human evolution’.
href:rstb20110266.pdf
ArticleID:rstb20110266
istex:66E99459D34C131B72C8EFE2D708358F20E79A84
ark:/67375/V84-NFRWCSC0-W
Discussion Meeting Issue 'Immunity, infection, migration and human evolution' organized and edited by Danny Altmann, Francois Balloux and Rosemary Boyton
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
OpenAccessLink https://proxy.k.utb.cz/login?url=https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2011.0266
PMID 22312047
PQID 1008824712
PQPubID 23462
PageCount 12
ParticipantIDs royalsociety_journals_RSTBv367i1590_0831063045_zip_rstb_367_issue_1590_rstb_2011_0266_rstb_2011_0266
unpaywall_primary_10_1098_rstb_2011_0266
jstor_primary_41441733
proquest_miscellaneous_1008824712
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3267113
pubmed_primary_22312047
crossref_primary_10_1098_rstb_2011_0266
crossref_citationtrail_10_1098_rstb_2011_0266
istex_primary_ark_67375_V84_NFRWCSC0_W
proquest_miscellaneous_920369760
royalsociety_journals_10_1098_rstb_2011_0266
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-03-19
20120319
2012-Mar-19
PublicationDateYYYYMMDD 2012-03-19
PublicationDate_xml – month: 3
  year: 2012
  text: 20120319
  day: 19
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Philosophical transactions of the Royal Society of London. Series B. Biological sciences
PublicationTitleAbbrev Phil. Trans. R. Soc. B
PublicationTitleAlternate Phil. Trans. R. Soc. B
PublicationYear 2012
Publisher The Royal Society
Publisher_xml – name: The Royal Society
References e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_28_2
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_87_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_85_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_24_2
e_1_3_2_66_2
e_1_3_2_89_2
e_1_3_2_60_2
e_1_3_2_83_2
e_1_3_2_81_2
e_1_3_2_9_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_52_2
Dohring C. (e_1_3_2_62_2) 1996; 156
e_1_3_2_73_2
e_1_3_2_5_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_58_2
e_1_3_2_79_2
e_1_3_2_3_2
e_1_3_2_14_2
e_1_3_2_35_2
e_1_3_2_56_2
e_1_3_2_77_2
e_1_3_2_92_2
e_1_3_2_50_2
e_1_3_2_71_2
e_1_3_2_90_2
Redman C. W. (e_1_3_2_86_2) 1984; 52
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_65_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_63_2
e_1_3_2_84_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_67_2
e_1_3_2_88_2
e_1_3_2_61_2
e_1_3_2_82_2
e_1_3_2_80_2
Winter C. C. (e_1_3_2_47_2) 1997; 158
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_4_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_78_2
e_1_3_2_2_2
e_1_3_2_91_2
e_1_3_2_72_2
e_1_3_2_70_2
Winter C. C. (e_1_3_2_69_2) 1998; 161
15632087 - Genome Res. 2005 Jan;15(1):25-35
21214544 - Immunology. 2011 Mar;132(3):315-25
9114037 - Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4604-9
11955593 - Mol Immunol. 2002 May;38(14):1007-21
21206914 - PLoS One. 2010;5(12):e15115
10781084 - Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83
19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72
21614583 - Immunogenetics. 2011 Sep;63(9):577-85
20145268 - Haematologica. 2010 Aug;95(8):1381-8
19265140 - J Immunol. 2009 Mar 15;182(6):3618-27
21079681 - PLoS Genet. 2010 Nov;6(11):e1001192
9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9
16533882 - J Exp Med. 2006 Mar 20;203(3):633-45
15194195 - Gene. 2004 Jun 23;335:121-31
20981092 - Nature. 2010 Oct 28;467(7319):1061-73
20147700 - Blood. 2010 Sep 9;116(10):1637-47
19837691 - Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7
19828694 - Blood. 2009 Dec 10;114(25):5182-90
20972337 - J Clin Invest. 2010 Nov;120(11):4102-10
10894168 - Immunity. 2000 Jun;12(6):687-98
10190900 - J Exp Med. 1999 Apr 5;189(7):1093-100
15477349 - J Exp Med. 2004 Oct 18;200(8):957-65
21411368 - Trends Immunol. 2011 May;32(5):219-24
18635379 - Semin Immunol. 2008 Dec;20(6):343-52
12370253 - J Exp Med. 2002 Oct 7;196(7):911-21
19834558 - PLoS Genet. 2009 Oct;5(10):e1000688
16132082 - PLoS Genet. 2005 Aug;1(2):129-39
15297676 - Science. 2004 Aug 6;305(5685):872-4
20439706 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5
9645365 - Eur J Immunol. 1998 Jun;28(6):1839-46
20026738 - J Immunol. 2010 Feb 1;184(3):1379-91
7931060 - J Exp Med. 1994 Oct 1;180(4):1235-42
21187902 - PLoS Genet. 2010 Dec;6(12):e1001249
11254692 - J Immunol. 2001 Apr 1;166(7):4380-90
18263639 - Hum Reprod. 2008 Apr;23(4):972-6
21106246 - Mol Immunol. 2011 Jan;48(4):553-62
20630802 - Trends Immunol. 2010 Aug;31(8):289-94
17450355 - Immunogenetics. 2007 Jun;59(6):517-22
11896281 - Science. 2002 Mar 15;295(5562):2097-100
19005473 - Genes Immun. 2009 Mar;10(2):162-73
16901727 - Immunity. 2006 Aug;25(2):331-42
16698429 - Hum Immunol. 2006 Jan-Feb;67(1-2):85-93
11870625 - Eur J Immunol. 2002 Mar;32(3):810-7
8617928 - J Immunol. 1996 May 1;156(9):3098-101
15162437 - Eur J Immunol. 2004 Jun;34(6):1673-9
18583565 - Blood. 2008 Sep 15;112(6):2369-80
20802150 - J Immunol. 2010 Oct 1;185(7):4233-7
9486650 - Nature. 1998 Feb 19;391(6669):795-9
16868549 - Nat Rev Immunol. 2006 Aug;6(8):584-94
15719024 - Nat Rev Immunol. 2005 Mar;5(3):201-14
12618911 - Immunogenetics. 2003 Feb;54(11):782-90
18945962 - Blood. 2009 Jan 15;113(3):726-32
9126959 - J Immunol. 1997 May 1;158(9):4026-8
9670929 - J Immunol. 1998 Jul 15;161(2):571-7
20483783 - J Immunol. 2010 Jun 1;184(11):6199-208
6204930 - Immunology. 1984 Jul;52(3):457-68
18595730 - Semin Immunol. 2008 Dec;20(6):321-30
17496894 - Nat Genet. 2007 Jun;39(6):733-40
12391228 - J Immunol. 2002 Nov 1;169(9):5118-29
9430221 - Immunity. 1997 Dec;7(6):753-63
2201309 - Immunol Today. 1990 Jul;11(7):237-44
21062830 - Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9
12077248 - J Immunol. 2002 Jul 1;169(1):220-9
17202323 - J Immunol. 2007 Jan 15;178(2):647-51
20805421 - J Immunol. 2010 Oct 1;185(7):4238-51
9174606 - Eur J Immunol. 1997 May;27(5):1164-9
19265141 - J Immunol. 2009 Mar 15;182(6):3628-37
16911775 - BMC Genomics. 2006;7:209
21212348 - Science. 2011 Jan 7;331(6013):44-9
16738943 - Immunogenetics. 2006 Jun;58(5-6):474-80
2543925 - N Engl J Med. 1989 Jun 29;320(26):1731-5
11751968 - J Immunol. 2002 Jan 1;168(1):240-52
21690332 - J Immunol. 2011 Jul 1;187(1):11-9
15203220 - Genomics. 2004 Jul;84(1):218-21
17182537 - J Immunol. 2007 Jan 1;178(1):33-7
14688344 - J Immunol. 2004 Jan 1;172(1):356-69
21199942 - Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1022-7
19009288 - Immunogenetics. 2009 Jan;61(1):27-41
9126935 - J Exp Med. 1997 Apr 21;185(8):1523-8
15731175 - Blood. 2005 Jun 15;105(12):4878-84
19752231 - J Immunol. 2009 Oct 1;183(7):4569-82
16546094 - Immunity. 2006 Mar;24(3):249-57
9177214 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6313-8
20061017 - Placenta. 2010 Mar;31 Suppl:S87-92
19304956 - Blood. 2009 Jul 2;114(1):95-104
18977671 - Semin Immunol. 2008 Dec;20(6):369-75
17579070 - J Immunol. 2007 Jul 1;179(1):491-504
8476574 - Annu Rev Immunol. 1993;11:613-35
9826699 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31
18941220 - J Immunol. 2008 Nov 1;181(9):6293-300
References_xml – ident: e_1_3_2_42_2
  doi: 10.4049/jimmunol.0901734
– ident: e_1_3_2_39_2
  doi: 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E
– ident: e_1_3_2_14_2
  doi: 10.4049/jimmunol.1000078
– volume: 156
  start-page: 3098
  year: 1996
  ident: e_1_3_2_62_2
  article-title: A human killer inhibitory receptor specific for HLA-A
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.156.9.3098
– ident: e_1_3_2_52_2
  doi: 10.1093/nar/gkq1128
– ident: e_1_3_2_74_2
  doi: 10.1016/j.it.2010.05.007
– ident: e_1_3_2_43_2
  doi: 10.4049/jimmunol.178.1.33
– ident: e_1_3_2_64_2
  doi: 10.4049/jimmunol.178.2.647
– ident: e_1_3_2_15_2
  doi: 10.1146/annurev.iy.11.040193.003145
– ident: e_1_3_2_59_2
  doi: 10.4049/jimmunol.0803401
– ident: e_1_3_2_20_2
  doi: 10.4049/jimmunol.0803026
– ident: e_1_3_2_79_2
  doi: 10.1016/j.smim.2008.06.003
– ident: e_1_3_2_11_2
  doi: 10.1016/0167-5699(90)90097-S
– ident: e_1_3_2_32_2
  doi: 10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P
– ident: e_1_3_2_66_2
  doi: 10.1073/pnas.95.24.14326
– ident: e_1_3_2_72_2
  doi: 10.1016/j.humimm.2005.11.007
– ident: e_1_3_2_73_2
  doi: 10.1182/blood-2009-12-256586
– ident: e_1_3_2_9_2
  doi: 10.1084/jem.20051884
– ident: e_1_3_2_35_2
  doi: 10.1007/s00251-007-0214-x
– ident: e_1_3_2_60_2
  doi: 10.1111/j.1365-2567.2010.03398.x
– ident: e_1_3_2_51_2
  doi: 10.1073/pnas.94.12.6313
– ident: e_1_3_2_90_2
  doi: 10.1126/science.1097670
– ident: e_1_3_2_22_2
  doi: 10.4049/jimmunol.0903016
– ident: e_1_3_2_61_2
  doi: 10.1016/j.gene.2004.03.018
– ident: e_1_3_2_24_2
  doi: 10.1371/journal.pone.0015115
– ident: e_1_3_2_71_2
  doi: 10.1007/s00251-006-0108-3
– ident: e_1_3_2_28_2
  doi: 10.1016/j.smim.2008.09.007
– ident: e_1_3_2_29_2
  doi: 10.4049/jimmunol.169.1.220
– ident: e_1_3_2_77_2
  doi: 10.1182/blood-2009-07-231977
– ident: e_1_3_2_85_2
  doi: 10.1016/j.placenta.2009.12.022
– ident: e_1_3_2_31_2
  doi: 10.1016/S1074-7613(00)80219-8
– ident: e_1_3_2_33_2
  doi: 10.4049/jimmunol.172.1.356
– ident: e_1_3_2_50_2
  doi: 10.1084/jem.185.8.1523
– ident: e_1_3_2_5_2
  doi: 10.1016/j.immuni.2006.06.013
– ident: e_1_3_2_13_2
  doi: 10.4049/jimmunol.0902332
– ident: e_1_3_2_3_2
  doi: 10.1126/science.1198687
– ident: e_1_3_2_92_2
  doi: 10.1371/journal.pgen.1001249
– ident: e_1_3_2_88_2
  doi: 10.1016/j.it.2011.02.003
– ident: e_1_3_2_48_2
  doi: 10.4049/jimmunol.181.9.6293
– ident: e_1_3_2_75_2
  doi: 10.1038/gene.2008.91
– ident: e_1_3_2_27_2
  doi: 10.1007/s00251-002-0529-6
– ident: e_1_3_2_36_2
  doi: 10.1186/1471-2164-7-209
– ident: e_1_3_2_37_2
  doi: 10.1016/j.smim.2008.05.004
– ident: e_1_3_2_84_2
  doi: 10.1172/JCI43998
– ident: e_1_3_2_6_2
  doi: 10.1182/blood-2008-03-143727
– ident: e_1_3_2_2_2
  doi: 10.1038/nri1570
– ident: e_1_3_2_40_2
  doi: 10.1002/eji.1830270517
– ident: e_1_3_2_53_2
  doi: 10.1182/blood-2008-07-171926
– ident: e_1_3_2_23_2
  doi: 10.1007/s00251-008-0342-y
– ident: e_1_3_2_68_2
  doi: 10.1084/jem.189.7.1093
– ident: e_1_3_2_25_2
  doi: 10.1101/gr.2381205
– ident: e_1_3_2_55_2
  doi: 10.3324/haematol.2009.021121
– volume: 161
  start-page: 571
  year: 1998
  ident: e_1_3_2_69_2
  article-title: Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.161.2.571
– ident: e_1_3_2_45_2
  doi: 10.1016/S0161-5890(02)00030-5
– ident: e_1_3_2_10_2
  doi: 10.1007/978-3-642-48287-8
– ident: e_1_3_2_65_2
  doi: 10.1002/eji.1830271203
– ident: e_1_3_2_76_2
  doi: 10.1073/pnas.0906051106
– ident: e_1_3_2_91_2
  doi: 10.1038/ng2035
– ident: e_1_3_2_7_2
  doi: 10.1182/blood-2008-10-184549
– ident: e_1_3_2_8_2
  doi: 10.1016/j.immuni.2006.03.006
– ident: e_1_3_2_41_2
  doi: 10.1073/pnas.0913745107
– ident: e_1_3_2_87_2
  doi: 10.1073/pnas.1003865108
– ident: e_1_3_2_46_2
  doi: 10.1016/j.molimm.2010.10.014
– volume: 158
  start-page: 4026
  year: 1997
  ident: e_1_3_2_47_2
  article-title: A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.158.9.4026
– ident: e_1_3_2_80_2
  doi: 10.1371/journal.pgen.1001192
– ident: e_1_3_2_21_2
  doi: 10.1371/journal.pgen.1000688
– ident: e_1_3_2_44_2
  doi: 10.1002/eji.200425089
– ident: e_1_3_2_58_2
  doi: 10.1007/s00251-011-0535-7
– ident: e_1_3_2_63_2
  doi: 10.1084/jem.180.4.1235
– ident: e_1_3_2_30_2
  doi: 10.4049/jimmunol.166.7.4380
– ident: e_1_3_2_78_2
  doi: 10.4049/jimmunol.169.9.5118
– ident: e_1_3_2_83_2
  doi: 10.1084/jem.20041214
– ident: e_1_3_2_54_2
  doi: 10.1182/blood-2004-12-4825
– ident: e_1_3_2_26_2
  doi: 10.4049/jimmunol.179.1.491
– ident: e_1_3_2_38_2
  doi: 10.1016/j.ygeno.2004.01.010
– ident: e_1_3_2_57_2
  doi: 10.4049/jimmunol.1001494
– ident: e_1_3_2_12_2
  doi: 10.1038/nature09534
– ident: e_1_3_2_19_2
  doi: 10.4049/jimmunol.168.1.240
– ident: e_1_3_2_67_2
  doi: 10.1084/jem.20091010
– ident: e_1_3_2_82_2
  doi: 10.1093/humrep/den011
– ident: e_1_3_2_81_2
  doi: 10.1084/jem.20020304
– ident: e_1_3_2_89_2
  doi: 10.1056/NEJM198906293202605
– ident: e_1_3_2_4_2
  doi: 10.1038/nri1897
– ident: e_1_3_2_18_2
  doi: 10.1038/35869
– ident: e_1_3_2_16_2
  doi: 10.1073/pnas.080588597
– ident: e_1_3_2_49_2
  doi: 10.1073/pnas.94.9.4604
– volume: 52
  start-page: 457
  year: 1984
  ident: e_1_3_2_86_2
  article-title: Class I major histocompatibility complex antigens on human extra-villous trophoblast
  publication-title: Immunology
– ident: e_1_3_2_17_2
  doi: 10.1371/journal.pgen.0010027
– ident: e_1_3_2_56_2
  doi: 10.1126/science.1068440
– ident: e_1_3_2_34_2
  doi: 10.1016/S1074-7613(00)80394-5
– ident: e_1_3_2_70_2
  doi: 10.4049/jimmunol.1001951
– reference: 8617928 - J Immunol. 1996 May 1;156(9):3098-101
– reference: 20802150 - J Immunol. 2010 Oct 1;185(7):4233-7
– reference: 8476574 - Annu Rev Immunol. 1993;11:613-35
– reference: 12370253 - J Exp Med. 2002 Oct 7;196(7):911-21
– reference: 10894168 - Immunity. 2000 Jun;12(6):687-98
– reference: 19265140 - J Immunol. 2009 Mar 15;182(6):3618-27
– reference: 12077248 - J Immunol. 2002 Jul 1;169(1):220-9
– reference: 20147700 - Blood. 2010 Sep 9;116(10):1637-47
– reference: 2201309 - Immunol Today. 1990 Jul;11(7):237-44
– reference: 20145268 - Haematologica. 2010 Aug;95(8):1381-8
– reference: 19752231 - J Immunol. 2009 Oct 1;183(7):4569-82
– reference: 9126959 - J Immunol. 1997 May 1;158(9):4026-8
– reference: 19005473 - Genes Immun. 2009 Mar;10(2):162-73
– reference: 9645365 - Eur J Immunol. 1998 Jun;28(6):1839-46
– reference: 16911775 - BMC Genomics. 2006;7:209
– reference: 20483783 - J Immunol. 2010 Jun 1;184(11):6199-208
– reference: 17579070 - J Immunol. 2007 Jul 1;179(1):491-504
– reference: 18941220 - J Immunol. 2008 Nov 1;181(9):6293-300
– reference: 19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72
– reference: 20630802 - Trends Immunol. 2010 Aug;31(8):289-94
– reference: 9486650 - Nature. 1998 Feb 19;391(6669):795-9
– reference: 21212348 - Science. 2011 Jan 7;331(6013):44-9
– reference: 15632087 - Genome Res. 2005 Jan;15(1):25-35
– reference: 12391228 - J Immunol. 2002 Nov 1;169(9):5118-29
– reference: 7931060 - J Exp Med. 1994 Oct 1;180(4):1235-42
– reference: 10781084 - Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83
– reference: 21106246 - Mol Immunol. 2011 Jan;48(4):553-62
– reference: 19304956 - Blood. 2009 Jul 2;114(1):95-104
– reference: 9126935 - J Exp Med. 1997 Apr 21;185(8):1523-8
– reference: 18945962 - Blood. 2009 Jan 15;113(3):726-32
– reference: 21079681 - PLoS Genet. 2010 Nov;6(11):e1001192
– reference: 18595730 - Semin Immunol. 2008 Dec;20(6):321-30
– reference: 20439706 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5
– reference: 6204930 - Immunology. 1984 Jul;52(3):457-68
– reference: 16868549 - Nat Rev Immunol. 2006 Aug;6(8):584-94
– reference: 10190900 - J Exp Med. 1999 Apr 5;189(7):1093-100
– reference: 18635379 - Semin Immunol. 2008 Dec;20(6):343-52
– reference: 21199942 - Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1022-7
– reference: 21411368 - Trends Immunol. 2011 May;32(5):219-24
– reference: 16546094 - Immunity. 2006 Mar;24(3):249-57
– reference: 18583565 - Blood. 2008 Sep 15;112(6):2369-80
– reference: 21187902 - PLoS Genet. 2010 Dec;6(12):e1001249
– reference: 9177214 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6313-8
– reference: 15731175 - Blood. 2005 Jun 15;105(12):4878-84
– reference: 17450355 - Immunogenetics. 2007 Jun;59(6):517-22
– reference: 19009288 - Immunogenetics. 2009 Jan;61(1):27-41
– reference: 16698429 - Hum Immunol. 2006 Jan-Feb;67(1-2):85-93
– reference: 20026738 - J Immunol. 2010 Feb 1;184(3):1379-91
– reference: 9670929 - J Immunol. 1998 Jul 15;161(2):571-7
– reference: 14688344 - J Immunol. 2004 Jan 1;172(1):356-69
– reference: 21206914 - PLoS One. 2010;5(12):e15115
– reference: 16738943 - Immunogenetics. 2006 Jun;58(5-6):474-80
– reference: 11955593 - Mol Immunol. 2002 May;38(14):1007-21
– reference: 2543925 - N Engl J Med. 1989 Jun 29;320(26):1731-5
– reference: 15162437 - Eur J Immunol. 2004 Jun;34(6):1673-9
– reference: 20805421 - J Immunol. 2010 Oct 1;185(7):4238-51
– reference: 21062830 - Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9
– reference: 17496894 - Nat Genet. 2007 Jun;39(6):733-40
– reference: 9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9
– reference: 16533882 - J Exp Med. 2006 Mar 20;203(3):633-45
– reference: 11254692 - J Immunol. 2001 Apr 1;166(7):4380-90
– reference: 21614583 - Immunogenetics. 2011 Sep;63(9):577-85
– reference: 18263639 - Hum Reprod. 2008 Apr;23(4):972-6
– reference: 20972337 - J Clin Invest. 2010 Nov;120(11):4102-10
– reference: 15194195 - Gene. 2004 Jun 23;335:121-31
– reference: 20061017 - Placenta. 2010 Mar;31 Suppl:S87-92
– reference: 18977671 - Semin Immunol. 2008 Dec;20(6):369-75
– reference: 17182537 - J Immunol. 2007 Jan 1;178(1):33-7
– reference: 21690332 - J Immunol. 2011 Jul 1;187(1):11-9
– reference: 11870625 - Eur J Immunol. 2002 Mar;32(3):810-7
– reference: 19834558 - PLoS Genet. 2009 Oct;5(10):e1000688
– reference: 9174606 - Eur J Immunol. 1997 May;27(5):1164-9
– reference: 15477349 - J Exp Med. 2004 Oct 18;200(8):957-65
– reference: 15297676 - Science. 2004 Aug 6;305(5685):872-4
– reference: 15719024 - Nat Rev Immunol. 2005 Mar;5(3):201-14
– reference: 19828694 - Blood. 2009 Dec 10;114(25):5182-90
– reference: 19837691 - Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7
– reference: 16901727 - Immunity. 2006 Aug;25(2):331-42
– reference: 11896281 - Science. 2002 Mar 15;295(5562):2097-100
– reference: 19265141 - J Immunol. 2009 Mar 15;182(6):3628-37
– reference: 12618911 - Immunogenetics. 2003 Feb;54(11):782-90
– reference: 15203220 - Genomics. 2004 Jul;84(1):218-21
– reference: 17202323 - J Immunol. 2007 Jan 15;178(2):647-51
– reference: 9430221 - Immunity. 1997 Dec;7(6):753-63
– reference: 9114037 - Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4604-9
– reference: 9826699 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31
– reference: 11751968 - J Immunol. 2002 Jan 1;168(1):240-52
– reference: 21214544 - Immunology. 2011 Mar;132(3):315-25
– reference: 16132082 - PLoS Genet. 2005 Aug;1(2):129-39
– reference: 20981092 - Nature. 2010 Oct 28;467(7319):1061-73
SSID ssj0009574
Score 2.4619343
SecondaryResourceType review_article
Snippet In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
royalsociety
jstor
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 800
SubjectTerms Animals
Balancing Selection
Epitopes
Evolution
Evolution, Molecular
Genetics, Population
Haplotypes
Haplotypes - genetics
Histocompatibility Antigens Class I - metabolism
HLA antigens
HLA C antigens
Humans
Ligands
Major Histocompatibility Complex
Models, Molecular
Natural Killer Cells
Pan troglodytes
Primates
Primates - genetics
Primates - immunology
Receptors
Receptors, KIR - genetics
Receptors, KIR - metabolism
Review
Species Specificity
T lymphocytes
Title Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules
URI https://api.istex.fr/ark:/67375/V84-NFRWCSC0-W/fulltext.pdf
https://www.jstor.org/stable/41441733
https://royalsocietypublishing.org/doi/full/10.1098/rstb.2011.0266
https://www.ncbi.nlm.nih.gov/pubmed/22312047
https://www.proquest.com/docview/1008824712
https://www.proquest.com/docview/920369760
https://pubmed.ncbi.nlm.nih.gov/PMC3267113
https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2011.0266
UnpaywallVersion publishedVersion
Volume 367
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1471-2970
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009574
  issn: 1471-2970
  databaseCode: KQ8
  dateStart: 18870101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1471-2970
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009574
  issn: 1471-2970
  databaseCode: KQ8
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1471-2970
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0009574
  issn: 1471-2970
  databaseCode: DIK
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1471-2970
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009574
  issn: 1471-2970
  databaseCode: GX1
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1471-2970
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0009574
  issn: 1471-2970
  databaseCode: RPM
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwED5BK5j4AKwwCILJSAiGRCAvbpN8HBXVBqJC28rgkxUnjlbapVFfxrofwO_mzk6jdrQCia_N1XHP5_Nd77nHAC8oSfY9mdlcptzmLo_tSErMUnislCMTqr0R2qLbOujxj9-aCzQh9cKMKWmeGMBiUf0Ro0v6tMeLNCs5kMJ3GB3JkoMTT5mbUG81MRyvQb3X_bL_XXPstXC3c990GAWu7UWBUxE3Xh9g5WCqk44vFxjFddHnGhDl8tzvwNYsL-L5z3g4XDqwOvdALn6qwakM3s5wFsnVNRbI_9LFfbhbhrNs39jfNtxQeQNumQsu5w24_bks3Tdgu_QiE7ZXUl2_fgC_dA3BpnZPgiwxdVHuBDbK2EC3KTIqLbA-tbGMiL2EkPP2sD9QDH21KlBvrAJBme-dxz_wQ02krBH2UwMAnjMNn1eXLKGMgR2yc3M1sJo8hF7nw0n7wC5vhrATTMCmdqpiXE80MzeOOSZVktqwQjfzpaMyTJLSNMXQxEu5xHBV-k10U6mnvEhxmWTEaLgDtXyUq8fAuIpSHkvXCVXEE0eGYULdvDJEzybDyLXAXpiFSEradLq9YyhM-T4UpHtBuhekewteVfKFIQzZKPlSW1klFo8HBLMLmuJryEW3c3TaPm474tSCHW2GlSCnLDjwfQueL-xSoFeg9YhzNZpNiIkaUyfUkWcB2yATUQ0ao1HHgkfGlKsXYMzoeg4PLAhWjLwSIFLy1Sd5_0yTk2M6ELguTu3NsvmK0jNONuoiXS9-dHzy_sJvBX0Mux2hr8VrUXFfXPULMwY-FNpHCS2yOu4fr9mrduVfVufJv4s-hdp0PFPPMDqdyl3Myw4_7ZZe6Dd9PJFS
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwED5BK0B8AFYYBAEyEoIhEciL2yQfR0U1kKjQtjL2yYoTR4R2adSXse4H8Lu5s9OoHa1A4mtzddzz-XzXe-4xwAtKkn1PZjaXKbe5y2M7khKzFB4r5ciEam-Etuh3Dgb807f2Ek1IvTATSpqnBrBY1n_E6JI-7fEyzSoOpPAdRkey4uDEU-Y6NDttDMcb0Bz0v-yfao69Du527psOo8C1vShwauLGqwOsHUxN0vHFEqO4KfrcAKJcnfttuDUvynjxMx6NVg6s3l2Qy59qcCrDt3OcRXJ5hQXyv3RxD-5U4SzbN_a3A9dU0YIb5oLLRQtufq5K9y3YqbzIlO1VVNev78MvXUOwqd2TIEtMnVc7gY0zNtRtioxKCyynNpYxsZcQct4e5UPF0FerEvXGahCU-d5Z_AM_1ETKGmE_MwDgBdPweXXBEsoY2Ed2Zq4GVtMHMOh9OO4e2NXNEHaCCdjMTlWM64lm5sYxx6RKUhtW6Ga-dFSGSVKaphiaeCmXGK5Kv41uKvWUFykuk4wYDXehUYwL9QgYV1HKY-k6oYp44sgwTKibV4bo2WQYuRbYS7MQSUWbTrd3jIQp34eCdC9I94J0b8GrWr40hCFbJV9qK6vF4smQYHZBW3wNuej3Dk-6R11HnFiwq82wFuSUBQe-b8HzpV0K9Aq0HnGhxvMpMVFj6oQ68ixgW2QiqkFjNOpY8NCYcv0CjBldz-GBBcGakdcCREq-_qTIv2tyckwHAtfFqb1ZNV9RecbpVl2km8UPj47fn_udIMew2xH6WrwOFffFZV6aMfCh0D5KaJH1cf94zV69K_-yOo__XfQJNGaTuXqK0elMPqv8z28a6JBZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human-specific+evolution+of+killer+cell+immunoglobulin-like+receptor+recognition+of+major+histocompatibility+complex+class+I+molecules&rft.jtitle=Philosophical+transactions+of+the+Royal+Society+of+London.+Series+B.+Biological+sciences&rft.au=Parham%2C+Peter&rft.au=Norman%2C+Paul+J.&rft.au=Abi-Rached%2C+Laurent&rft.au=Guethlein%2C+Lisbeth+A.&rft.date=2012-03-19&rft.issn=0962-8436&rft.eissn=1471-2970&rft.volume=367&rft.issue=1590&rft.spage=800&rft.epage=811&rft_id=info:doi/10.1098%2Frstb.2011.0266&rft.externalDBID=n%2Fa&rft.externalDocID=10_1098_rstb_2011_0266
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-8436&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-8436&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-8436&client=summon